Cargando…

Vaccine against SARS-CoV-2 in previously infected health care workers

Detalles Bibliográficos
Autor principal:	Parisi, Saverio Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387027/ https://www.ncbi.nlm.nih.gov/pubmed/34454402 http://dx.doi.org/10.1016/j.ebiom.2021.103556

Ejemplares similares

Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2
por: Sexton, Mary Elizabeth, et al.
Publicado: (2021)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
por: Soysal, Ahmet, et al.
Publicado: (2021)

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?
por: Pean De Ponfilly, G., et al.
Publicado: (2021)

Surveillance of SARS‐CoV‐2 infection among frontline health care workers in Wuhan during COVID‐19 outbreak
por: Tong, Xin, et al.
Publicado: (2020)

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
por: Gupta, Aayush, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
por: Nunes, Marta C., et al.
Publicado: (2022)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
por: Vicenti, Ilaria, et al.
Publicado: (2021)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
por: Immordino, Palmira, et al.
Publicado: (2023)

Acute kidney injury in SARS-CoV-2 infected patients
por: Fanelli, Vito, et al.
Publicado: (2020)

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California
por: Keehner, Jocelyn, et al.
Publicado: (2021)

Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
por: Parisi, Saverio Giuseppe, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

SARS-CoV-2 vaccines: anamnestic response in previously infected recipients
por: Purushotham, Jyothi N., et al.
Publicado: (2021)

Usefulness and Limitations of Anti-S IgG Assay in Detecting Previous SARS-CoV-2 Breakthrough Infection in Fully Vaccinated Healthcare Workers
por: Spiteri, Gianluca, et al.
Publicado: (2022)

Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees
por: Kojima, N., et al.
Publicado: (2022)

Anti-SARS-CoV-2 IgG antibodies induced by the BNT162b2 mRNA vaccine is age-dependent and influenced by a previous natural SARS-CoV-2 infection
por: Pratò, Simone, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination Rate and SARS-CoV-2 Infection of Health Care Workers in Aerosol-Generating Medical Disciplines
por: Muzalyova, Anna, et al.
Publicado: (2022)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination
por: Terbsiri, Varalee, et al.
Publicado: (2023)

BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects
por: Vicenti, Ilaria, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic
por: Barrett, Emily S., et al.
Publicado: (2020)

Combination of antibody tests against SARS-CoV-2 for health care workers after vaccination
por: Kittanakom, Saranya, et al.
Publicado: (2022)

Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants
por: Ibarrondo, F. Javier, et al.
Publicado: (2021)

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
por: Ikizler, T. Alp, et al.
Publicado: (2021)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

Abrupt decreases in infectivity of SARS-CoV-2 in aerosols
por: Löndahl, Jakob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j2i2cfpe59a2smkham084m3qmi